These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7788011)
1. Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency. Leal-Cerro A; Garcia E; Astorga R; Casanueva FF; Dieguez C Eur J Endocrinol; 1995 Jun; 132(6):712-5. PubMed ID: 7788011 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885 [TBL] [Abstract][Full Text] [Related]
3. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6. Popovic V; Pekic S; Golubicic I; Doknic M; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 2002 May; 87(5):2095-9. PubMed ID: 11994347 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion. Bowers CY; Granda-Ayala R Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505 [TBL] [Abstract][Full Text] [Related]
5. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. Pombo M; Barreiro J; PeƱalva A; Peino R; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy. Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075 [TBL] [Abstract][Full Text] [Related]
7. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness. Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children. Mericq V; Cassorla F; Garcia H; Avila A; Bowers CY; Merriam GR J Clin Endocrinol Metab; 1995 May; 80(5):1681-4. PubMed ID: 7745018 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency. Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223 [TBL] [Abstract][Full Text] [Related]
11. Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH-releasing hexapeptide in normal adult subjects. Popovic V; Pekic S; Simic M; Damjanovic S; Micic D; Dieguez C; Casanueva FF Clin Endocrinol (Oxf); 2002 Jan; 56(1):89-94. PubMed ID: 11849251 [TBL] [Abstract][Full Text] [Related]
12. Observations on the stimulation of growth hormone secretion in patients with growth hormone deficiency. Kendall-Taylor P; Paxton A; Koppiker NP Metabolism; 1996 Aug; 45(8 Suppl 1):127-8. PubMed ID: 8769406 [TBL] [Abstract][Full Text] [Related]
13. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046 [TBL] [Abstract][Full Text] [Related]
14. Combined growth hormone-releasing hormone and growth hormone-releasing peptide-6 test for the evaluation of growth hormone secretion in children with growth hormone deficiency and growth hormone neurosecretory dysfunction. Spiliotis BE; Papadimitriou DT; Alexandrides TK; Karystianos C; Nikiforidis G; Vassilakos P; Beratis NG; Casanueva FF Horm Res; 2008; 70(4):215-23. PubMed ID: 18772594 [TBL] [Abstract][Full Text] [Related]
15. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man. Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750 [TBL] [Abstract][Full Text] [Related]
16. Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man. Pinto AC; Finamor FE; Lengyel AM Clin Endocrinol (Oxf); 1999 Oct; 51(4):409-14. PubMed ID: 10583306 [TBL] [Abstract][Full Text] [Related]
17. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone. Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Bellone J; Ghizzoni L; Aimaretti G; Volta C; Boghen MF; Bernasconi S; Ghigo E Eur J Endocrinol; 1995 Oct; 133(4):425-9. PubMed ID: 7581965 [TBL] [Abstract][Full Text] [Related]
19. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260 [TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6. Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]